{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:01:42Z","timestamp":1783191702510,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,9]]},"DOI":"10.7759\/cureus.87580","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T13:15:09Z","timestamp":1752066909000},"source":"Crossref","is-referenced-by-count":1,"title":["Behind the Headache: A Case of Cerebral Venous Thrombosis Associated With Hormonal Contraceptive Use"],"prefix":"10.7759","author":[{"given":"Ad\u00e9lia F","family":"S\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara G","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana S","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute C","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2015.5259","article-title":"Risk factors for venous thromboembolism among reproductive age women","volume":"25","author":"Westhoff CL","year":"2016","unstructured":"Westhoff CL, Yoon LS, Tang R, Pulido V, Eisenberger A. Risk factors for venous thromboembolism among reproductive age women. J Womens Health (Larchmt). 2016, 25:63-70. 10.1089\/jwh.2015.5259","journal-title":"J Womens Health (Larchmt)"},{"key":"ref2","article-title":"","author":"Sociedade Portuguesa da Contrace\u00e7\u00e3o","year":"2023","unstructured":"Sociedade Portuguesa da Contrace\u00e7\u00e3o, Sociedade Portuguesa de Ginecologia, Sociedade Portuguesa de Medicina de Reprodu\u00e7\u00e3o. Consenso Sobre Contrace\u00e7\u00e3o 2020. 2023. https:\/\/www.spdc.pt\/images\/2023\/Consenso_de_Contraceo_versao_adoptada_pela_DGS_2023.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.24950\/rspmi.289","article-title":"Cerebral venous thrombosis: 11 years in a stroke unit","volume":"29","author":"Carneiro P","year":"2022","unstructured":"Carneiro P, Damas C, Tavares J, Figueira M, Serra S, Guerreiro R, Matos R. Cerebral venous thrombosis: 11 years in a stroke unit. RPMI. 2022, 29:103-8. 10.24950\/rspmi.289","journal-title":"RPMI"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.037541","article-title":"Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study","volume":"53","author":"Yaghi S","year":"2022","unstructured":"Yaghi S, Shu L, Bakradze E, et al.. Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study. Stroke. 2022, 53:728-38. 10.1161\/STROKEAHA.121.037541","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0988-x","article-title":"Cerebral venous thrombosis: an update","volume":"19","author":"Ferro JM","year":"2019","unstructured":"Ferro JM, Aguiar de Sousa D. Cerebral venous thrombosis: an update. Curr Neurol Neurosci Rep. 2019, 19:74. 10.1007\/s11910-019-0988-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.104","article-title":"Cerebral venous thrombosis","volume":"13","author":"Silvis SM","year":"2017","unstructured":"Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017, 13:555-65. 10.1038\/nrneurol.2017.104","journal-title":"Nat Rev Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik G","year":"2024","unstructured":"Saposnik G, Bushnell C, Coutinho JM, et al.. Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. Stroke. 2024, 55:e77-90. 10.1161\/STR.0000000000000456","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1076029617727857","article-title":"Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use","volume":"24","author":"Dulicek P","year":"2018","unstructured":"Dulicek P, Ivanova E, Kostal M, Sadilek P, Beranek M, Zak P, Hirmerova J. Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use. Clin Appl Thromb Hemost. 2018, 24:797-802. 10.1177\/1076029617727857","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13381","article-title":"European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology","volume":"24","author":"Ferro JM","year":"2017","unstructured":"Ferro JM, Bousser MG, Canh\u00e3o P, et al.. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017, 24:1203-13. 10.1111\/ene.13381","journal-title":"Eur J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.038","article-title":"Continued existence of significant disparities in the technical practices\u00a0of sperm morphology assessment and the clinical implications: results of a French questionnaire","volume":"107","author":"Gatimel N","year":"2017","unstructured":"Gatimel N, Mansoux L, Moreau J, Parinaud J, L\u00e9andri RD. Continued existence of significant disparities in the technical practices\u00a0of sperm morphology assessment and the clinical implications: results of a French questionnaire. Fertil Steril. 2017, 107:365-372.e3. 10.1016\/j.fertnstert.2016.10.038","journal-title":"Fertil Steril"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.08.039","article-title":"Hormonal contraception and thrombosis","volume":"106","author":"Sitruk-Ware R","year":"2016","unstructured":"Sitruk-Ware R. Hormonal contraception and thrombosis. Fertil Steril. 2016, 106:1289-94. 10.1016\/j.fertnstert.2016.08.039","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13534","article-title":"Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study","volume":"172","author":"van Vlijmen EF","year":"2016","unstructured":"van Vlijmen EF, M\u00e4kelburg AB, Knol HM, Tichelaar VI, Kluin-Nelemans HC, Veeger NJ, Meijer K. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study. Br J Haematol. 2016, 172:636-8. 10.1111\/bjh.13534","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic M","year":"2018","unstructured":"Glisic M, Shahzad S, Tsoli S, et al.. Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis. Eur J Prev Cardiol. 2018, 25:1042-52. 10.1177\/2047487318774847","journal-title":"Eur J Prev Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo O","year":"2022","unstructured":"Heikinheimo O, Toffol E, Partonen T, But A, Latvala A, Haukka J. Systemic hormonal contraception and risk of venous thromboembolism. Acta Obstet Gynecol Scand. 2022, 101:846-55. 10.1111\/aogs.14384","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.134882","article-title":"Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study","volume":"101","author":"Le Moigne E","year":"2016","unstructured":"Le Moigne E, Tromeur C, Delluc A, et al.. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study. Haematologica. 2016, 101:e12-4. 10.3324\/haematol.2015.134882","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen AT","year":"2024","unstructured":"Nguyen AT, Curtis KM, Tepper NK, et al.. U.S. medical eligibility criteria for contraceptive use, 2024. MMWR Recomm Rep. 2024, 73:1-126. 10.15585\/mmwr.rr7304a1","journal-title":"MMWR Recomm Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15661","article-title":"Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: systematic review and meta-analysis","volume":"20","author":"Wiegers HM","year":"2022","unstructured":"Wiegers HM, Knijp J, van Es N, Coppens M, Moll S, Klok FA, Middeldorp S. Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: systematic review and meta-analysis. J Thromb Haemost. 2022, 20:1158-65. 10.1111\/jth.15661","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2022.10.009","article-title":"Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a\u00a0comparison of recurrence rates","volume":"21","author":"Wiegers HM","year":"2023","unstructured":"Wiegers HM, Knijp J, van Es N, Coppens M, Klok FA, Middeldorp S, Moll S. Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a\u00a0comparison of recurrence rates. J Thromb Haemost. 2023, 21:175-8. 10.1016\/j.jtha.2022.10.009","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"Verlaan JP","year":"2024","unstructured":"Verlaan JP, Stegeman BH, Timp JF, et al.. Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women. J Thromb Haemost. 2024, 22:2195-202. 10.1016\/j.jtha.2024.03.014","journal-title":"J Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377593-behind-the-headache-a-case-of-cerebral-venous-thrombosis-associated-with-hormonal-contraceptive-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T13:15:10Z","timestamp":1752066910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377593-behind-the-headache-a-case-of-cerebral-venous-thrombosis-associated-with-hormonal-contraceptive-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.87580","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}